Literature DB >> 31543148

FGF23 and inflammation-a vicious coalition in CKD.

Brian Czaya1, Christian Faul2.   

Abstract

High serum concentrations of the phosphaturic hormone, fibroblast growth factor 23 (FGF23), contribute to various tissue injuries. In chronic kidney disease, the sources of FGF23 and the stimuli that control FGF23 production differ from those in the physiologic scenario. Mediators of inflammation are intensively studied as potential factors that contribute to FGF23 elevations and thereby might function as drug targets to lower FGF23 levels. The present study focuses on tumor necrosis factor.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31543148     DOI: 10.1016/j.kint.2019.05.018

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion.

Authors:  Lian-Cheng Deng; Tahereh Alinejad; Saverio Bellusci; Jin-San Zhang
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

2.  Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.

Authors:  Brian Czaya; Kylie Heitman; Isaac Campos; Christopher Yanucil; Dominik Kentrup; David Westbrook; Orlando Gutierrez; Jodie L Babitt; Grace Jung; Isidro B Salusky; Mark Hanudel; Christian Faul
Journal:  Elife       Date:  2022-03-18       Impact factor: 8.713

Review 3.  The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration.

Authors:  Mariya Farooq; Abdul Waheed Khan; Moon Suk Kim; Sangdun Choi
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

4.  Inflammation in the early phase after kidney transplantation is associated with increased long-term all-cause mortality.

Authors:  Torbjørn Fossum Heldal; Anders Åsberg; Thor Ueland; Anna Varberg Reisaeter; Søren E Pischke; Tom Eirik Mollnes; Pål Aukrust; Anders Hartmann; Kristian Heldal; Trond Jenssen
Journal:  Am J Transplant       Date:  2022-04-29       Impact factor: 9.369

5.  FGF23, a novel muscle biomarker detected in the early stages of ALS.

Authors:  Ying Si; Mohamed Kazamel; Michael Benatar; Joanne Wuu; Yuri Kwon; Thaddaeus Kwan; Nan Jiang; Dominik Kentrup; Christian Faul; Lyndsy Alesce; Peter H King
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 6.  The Emerging Role of Innate Immunity in Chronic Kidney Diseases.

Authors:  Philip Chiu-Tsun Tang; Ying-Ying Zhang; Max Kam-Kwan Chan; Winson Wing-Yin Lam; Jeff Yat-Fai Chung; Wei Kang; Ka-Fai To; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

7.  Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study.

Authors:  Forough Saki; Azita Salehifar; Seyed Reza Kassaee; Gholamhossein Ranjbar Omrani
Journal:  BMC Nephrol       Date:  2020-11-16       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.